Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system
- PMID: 10505094
- DOI: 10.1038/sj.gt.3300895
Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system
Abstract
Lentiviruses infect both dividing and nondividing cells. In this study we characterized a lentiviral vector system consisting of a packaging vector (pHP) and a transducing vector (pTV) derived from a recombinant human immunodeficiency virus type 1 (HIV-1). In pHP, the long terminal repeats (LTRs), the 5' untranslated leader and portions of the env and nef genes were deleted. The leader sequence of pHP was substituted with a modified Rous sarcoma virus (RSV) 59 bp leader containing a mutated RSV gag AUG and a functional 5' splice site. The pHP construct was found to direct Gag-Pol synthesis as efficiently as wild-type HIV-1. The pTV construct contains sequences required for RNA packaging, reverse transcription and integration, but lacks viral genes. Co-transfection of pHP, pTV and a vesicular stomatitis virus G (VSV-G) envelope plasmid produced vectors at titers of 10(5)-10(6) transducing units per milliliter in 48 h. Replication-competent virus (RCV) was not detected when deletions were made in the env gene in pHP. The ability of this vector system to transduce dividing and nondividing cell in vitro and in vivo was also demonstrated. Compared with a Moloney murine leukemia virus (MLV) vector, the HP/TV vectors transduced human muscle-, kidney-, liver-derived cell lines and CD34+ primary hematopoietic progenitor cells more efficiently. Although the levels of the pTV transgene expression were high soon after transduction, the expression tended to decrease with time due either to the loss of proviral DNA or to the inactivation of promoter activity, which was found to be cell type-dependent. Analyses of extrachromosomal DNA showed that the unintegrated proviral DNA of lentiviral vectors survived much longer than that of the retroviral vectors. We demonstrate that the HP/TV vector is capable of high efficiency transduction and that long-term expression of lentiviral vectors is dependent on target cell type, the internal promoter and the transgene itself in the transducing vector.
Similar articles
-
Use of HIV as a gene transfer vector.Acta Biochim Pol. 2009;56(4):531-95. Epub 2009 Nov 23. Acta Biochim Pol. 2009. PMID: 19936329 Review.
-
Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.J Gene Med. 2005 Jun;7(6):818-34. doi: 10.1002/jgm.726. J Gene Med. 2005. PMID: 15693055
-
Self-inactivating lentiviral vectors with U3 and U5 modifications.Virology. 1999 Aug 15;261(1):120-32. doi: 10.1006/viro.1999.9850. Virology. 1999. PMID: 10441560
-
Retroviral vectors for liver-directed gene therapy.Semin Liver Dis. 1999;19(1):27-37. doi: 10.1055/s-2007-1007095. Semin Liver Dis. 1999. PMID: 10349681 Review.
-
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.Nat Genet. 1997 Nov;17(3):314-7. doi: 10.1038/ng1197-314. Nat Genet. 1997. PMID: 9354796
Cited by
-
Real-time Fluorescent PCR Techniques to Study Microbial-Host Interactions.Methods Microbiol. 2004;34:255-330. doi: 10.1016/S0580-9517(04)34010-9. Epub 2004 Dec 1. Methods Microbiol. 2004. PMID: 38620210 Free PMC article. Review.
-
CRISPR library screening to develop HEK293-derived cell lines with improved lentiviral vector titers.Front Genome Ed. 2023 Jul 13;5:1218328. doi: 10.3389/fgeed.2023.1218328. eCollection 2023. Front Genome Ed. 2023. PMID: 37520398 Free PMC article.
-
Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?Genes Dis. 2022 Apr 2;10(5):1937-1955. doi: 10.1016/j.gendis.2022.03.007. eCollection 2023 Sep. Genes Dis. 2022. PMID: 37492721 Free PMC article. Review.
-
Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.Mol Med. 2023 Jun 12;29(1):74. doi: 10.1186/s10020-023-00680-z. Mol Med. 2023. PMID: 37308845 Free PMC article.
-
Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors.Viruses. 2023 Apr 19;15(4):1001. doi: 10.3390/v15041001. Viruses. 2023. PMID: 37112982 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous